Associated Banc-Corp (ASB.PE) stock
ASB.PENYSEState Commercial BanksFiscal year ends December 31Also trades as ASB, ASB.PF, ASBA
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 10-Q on Oct 27, 2026Score 17/305% below fair value
$17.65−0.14 (-0.79%)
Close on Oct 30, 2026Market cap $3.33BP/E 6.4Yield 5.27%
Associated Banc-Corp EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Associated Banc-Corp's EPS for the twelve months ending Dec 31, 2025 was $2.77, up 284.7% year over year. For fiscal 2025 it was $2.77, up 284.7% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is $2.77 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.77 | +284.7% |
| FY2024 | Dec 31, 2024 | $0.72 | -36.3% |
| FY2023 | Dec 31, 2023 | $1.13 | -51.7% |
| FY2022 | Dec 31, 2022 | $2.34 | +7.3% |
| FY2021 | Dec 31, 2021 | $2.18 | +17.2% |
| FY2020 | Dec 31, 2020 | $1.86 | -2.6% |
| FY2019 | Dec 31, 2019 | $1.91 | +1.1% |
| FY2018 | Dec 31, 2018 | $1.89 | +33.1% |
| FY2017 | Dec 31, 2017 | $1.42 | +12.7% |
| FY2016 | Dec 31, 2016 | $1.26 | +5.9% |
| FY2015 | Dec 31, 2015 | $1.19 | +2.6% |
| FY2014 | Dec 31, 2014 | $1.16 | +5.5% |
| FY2013 | Dec 31, 2013 | $1.10 | +10.0% |
| FY2012 | Dec 31, 2012 | $1.00 | +51.5% |
| FY2011 | Dec 31, 2011 | $0.66 | – |
| FY2010 | Dec 31, 2010 | -$0.18 | – |
| FY2009 | Dec 31, 2009 | -$1.26 | -197.7% |
| FY2008 | Dec 31, 2008 | $1.29 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0.81 | – |
| Q3 FY2025 | Sep 30, 2025 | $0.73 | +30.4% |
| Q2 FY2025 | Jun 30, 2025 | $0.65 | -12.2% |
| Q1 FY2025 | Mar 31, 2025 | $0.59 | +13.5% |
| Q4 FY2024 | Dec 31, 2024 | -$1.03 | – |
| Q3 FY2024 | Sep 30, 2024 | $0.56 | +5.7% |
| Q2 FY2024 | Jun 30, 2024 | $0.74 | +32.1% |
| Q1 FY2024 | Mar 31, 2024 | $0.52 | -21.2% |
| Q4 FY2023 | Dec 31, 2023 | -$0.62 | -188.6% |
| Q3 FY2023 | Sep 30, 2023 | $0.53 | -14.5% |
| Q2 FY2023 | Jun 30, 2023 | $0.56 | 0.0% |
| Q1 FY2023 | Mar 31, 2023 | $0.66 | +40.4% |
| Q4 FY2022 | Dec 31, 2022 | $0.70 | +42.9% |
| Q3 FY2022 | Sep 30, 2022 | $0.62 | +10.7% |
| Q2 FY2022 | Jun 30, 2022 | $0.56 | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | $0.47 | -19.0% |
| Q4 FY2021 | Dec 31, 2021 | $0.49 | +22.5% |
| Q3 FY2021 | Sep 30, 2021 | $0.56 | +115.4% |
| Q2 FY2021 | Jun 30, 2021 | $0.56 | -40.4% |
| Q1 FY2021 | Mar 31, 2021 | $0.58 | +114.8% |
| Q4 FY2020 | Dec 31, 2020 | $0.40 | -7.0% |
| Q3 FY2020 | Sep 30, 2020 | $0.26 | -46.9% |
| Q2 FY2020 | Jun 30, 2020 | $0.94 | +91.8% |
| Q1 FY2020 | Mar 31, 2020 | $0.27 | -46.0% |
| Q4 FY2019 | Dec 31, 2019 | $0.43 | -15.7% |
| Q3 FY2019 | Sep 30, 2019 | $0.49 | +2.1% |
| Q2 FY2019 | Jun 30, 2019 | $0.49 | -2.0% |
| Q1 FY2019 | Mar 31, 2019 | $0.50 | +25.0% |
| Q4 FY2018 | Dec 31, 2018 | $0.51 | +64.5% |
| Q3 FY2018 | Sep 30, 2018 | $0.48 | +17.1% |
| Q2 FY2018 | Jun 30, 2018 | $0.50 | +38.9% |
| Q1 FY2018 | Mar 31, 2018 | $0.40 | +14.3% |
| Q4 FY2017 | Dec 31, 2017 | $0.31 | -11.4% |
| Q3 FY2017 | Sep 30, 2017 | $0.41 | +20.6% |
| Q2 FY2017 | Jun 30, 2017 | $0.36 | +16.1% |
| Q1 FY2017 | Mar 31, 2017 | $0.35 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.35 | – |
| Q3 FY2016 | Sep 30, 2016 | $0.34 | – |
| Q2 FY2016 | Jun 30, 2016 | $0.31 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics